Viewing StudyNCT00425477



Ignite Creation Date: 2024-05-05 @ 5:17 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00425477
Status: COMPLETED
Last Update Posted: 2018-10-05
First Post: 2007-01-19

Brief Title: Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions & Keywords Data

Conditions:
Name
MyelodysplasticMyeloproliferative Diseases
Leukemia
Myelodysplastic Syndromes
Keywords:
Name View
adult acute myeloid leukemia with inv16p13q22 View
refractory anemia with excess blasts View
recurrent adult acute myeloid leukemia View
untreated adult acute myeloid leukemia View
secondary acute myeloid leukemia View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View
secondary myelodysplastic syndromes View
myelodysplasticmyeloproliferative disease unclassifiable View
refractory anemia with ringed sideroblasts View
refractory cytopenia with multilineage dysplasia View
chronic myelomonocytic leukemia View
adult acute myeloid leukemia with 11q23 MLL abnormalities View
adult acute minimally differentiated myeloid leukemia M0 View
adult acute myeloblastic leukemia without maturation M1 View
adult acute myeloblastic leukemia with maturation M2 View
adult acute myelomonocytic leukemia M4 View
adult acute monoblastic leukemia M5a View
adult acute monocytic leukemia M5b View
adult pure erythroid leukemia M6b View
adult erythroleukemia M6a View
adult acute megakaryoblastic leukemia M7 View
adult acute myeloid leukemia with t1616p13q22 View
adult acute myeloid leukemia with t821q22q22 View